What is ONI?
ONI Inc. is at the forefront of optical microscopy innovation, developing and offering super-resolution microscopes that push the boundaries of biological and materials science imaging. Headquartered in Oxford, United Kingdom, the company's technology enables researchers to visualize cellular structures and dynamic processes with unprecedented detail. This advanced capability is crucial for accelerating discoveries in fields ranging from drug development to fundamental biological research, positioning ONI as a key player in the scientific instrumentation market.
How much funding has ONI raised?
ONI has raised a total of $76.7M across 2 funding rounds:
Angel/Seed
$1.7M
Series B
$75M
Angel/Seed (2016): $1.7M with participation from Oxford Technology Management and Oxford Sciences Enterprises
Series B (2022): $75M led by ARCH Venture Partners, ARTIS Ventures, Casdin Capital, Vertical Venture Partners, and Section 32
Key Investors in ONI
ARCH Venture Partners
ARCH Venture Partners is a leading earlystage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
ARTIS Ventures
Artis Ventures is a dedicated venture capital fund focused on Tech Bio+Health, investing in innovative data-driven life sciences companies that aim to enhance human health and wellness. The company aims to create a significant global impact through investments in scalable medical technologies that leverage AI and engineering to develop personalized therapeutics and efficient drug discovery.
Vertical Venture Partners
Vertical Venture Partners is an early-stage venture capital firm that focuses on investing in enterprise technology companies targeting specific vertical markets. The firm seeks to partner with founders who possess a deep understanding of their industry, leveraging their extensive experience in operating and investing.
What's next for ONI?
The substantial enterprise-level funding, particularly the recent strategic investment, positions ONI for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the company's global reach. ONI's trajectory suggests a focus on solidifying its market leadership in super-resolution microscopy, potentially exploring new applications and technological advancements to maintain its competitive edge and drive innovation in scientific imaging.
See full ONI company page
